ACQUISITIONS, DIVESTITURES AND STRATEGIC INVESTMENTS - Divestiture of the Whole Blood Product Line and Strategic Investments (Details) - USD ($) $ in Thousands		3 Months Ended			6 Months Ended
	Jan. 13, 2025	Sep. 27, 2025	Dec. 28, 2024	Sep. 28, 2024	Sep. 27, 2025	Sep. 28, 2024	Mar. 29, 2025
Schedule of Investments [Line Items]
Inventories, net		$ (336,206)			$ (336,206)		$ (365,141)
Property, plant and equipment, net		(292,476)			(292,476)		$ (284,052)
Gain (loss) on investments		$ 0		$ 0	$ 0	$ 0
Disposal Group, Held-for-Sale, Not Discontinued Operations | Whole Blood Business
Schedule of Investments [Line Items]
Proceeds from divestiture	$ 43,300
Contingent consideration from divestiture	22,500
Disposal Group, Not Discontinued Operations | Whole Blood
Schedule of Investments [Line Items]
Proceeds from divestiture	$ 43,300
Revision of Prior Period, Reclassification, Adjustment
Schedule of Investments [Line Items]
Inventories, net			$ 26,400
Property, plant and equipment, net			7,800
Assets held for sale			$ 6,400